Synthesis and Inhibitory Effect of Novel Glycyrrhetinic Acid Derivatives on IL-1β-Induced Prostaglandin E2 Production in Normal Human Dermal Fibroblasts
-
- Tsukahara Michiko
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
-
- Nishino Takeshi
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
-
- Furuhashi Ikue
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
-
- Inoue Hideo
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
-
- Sato Toshitsugu
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
-
- Matsumoto Hiroatsu
- Research Laboratory, Minophagen Pharmaceutical Co., Ltd.
書誌事項
- タイトル別名
-
- Synthesis and Inhibitory Effect of Novel Glycyrrhetinic Acid Derivatives on IL-1.BETA.-Induced Prostaglandin E2 Production in Normal Human Dermal Fibroblasts
- Synthesis and Inhibitory Effect of Novel Glycyrrhetinic Acid Derivatives on IL 1 ベータ Induced Prostaglandin E2 Production in Normal Human Dermal Fibroblasts
- Synthesis and inhibitory effect of novel glycyrrhetinic acid derivatives on IL-1b-induced prostaglandin E2 production in normal human dermal fibroblasts
この論文をさがす
説明
Olean-11,13(18)-dien-3β,30-diol dihemiphthalate (3), which was derived from glycyrrhetinic acid (GA), has been reported to produce a potent of anti-inflammatory effect in in vivo assays. Using 3 as a lead compound, we attempted to synthesize some modified compounds which varied in the following; i) the position of a carboxyl group in the phthalate moiety, ii) the number of carboxyls attached to the benzoyl group, iii) conversion of benzene ring to another ring system, iv) the linkage form between the benzene ring and oleanene skeleton at position 3 and/or 30. These were screened for their inhibitory activity against interleukin-1β (IL-1β)-induced prostaglandin E2 (PGE2) production in normal human dermal fibroblasts (NHDF). Although conversion of the ortho-carboxyl group of 3 into the meta-position or the para-position led to an increase in inhibitory activity, the elimination or increase of the carboxyl group resulted in loss of the inhibitory activity. Conversion of the ester bond to the amide bond at position 3 and/or 30 of 3 did not contribute to a significant increase in inhibitory activity. On the other hand, among the derivatives possessing an anthranilic acid moiety at position 30 of 3β-O-acetyl-olean-11,13(18)-dien-30-oic acid (20), 3β-hydroxy-30-nor-olean-11,13(18)-dien-20β-[N-(2-carboxyphenyl)]carboxamide (30) showed the most potent inhibitory activity (IC50 1.0 μM) in this series.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 53 (9), 1103-1110, 2005
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679145717248
-
- NII論文ID
- 110003666320
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 7409033
-
- PubMed
- 16141576
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可